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In the article entitled “Farnesoid X Receptor Critically
Determines the Fibrotic Response in Mice but Is Ex-
pressed to a Low Extent in Human Hepatic Stellate Cells
and Periductal Myofibroblasts” (Volume 175, pages
2392–2405 of the December 2009 issue of The American
Journal of Pathology), several authors’ affiliations were
listed incorrectly. Marco Arrese, Margarita Pizarro, and
Nancy Solís are members of the Department of Gas-
troenterology and Facultad de Medicina, and Gonzalo
Carrasco is a member of the Department of Patho-
logy and Facultad de Medicina, Escuela de Medicina,
Pontificia Universidad Catolica de Chile, Santiago,
Chile.
In the article entitled “Down-Regulation of FXYD3 Ex-
pression in Human Lung Cancers: Its Mechanism and
Potential Role in Carcinogenesis” (Volume 175, pages
2646–2656 of the December 2009 issue), one author’s
affiliation was listed incorrectly. Haruhiko Sugimura is a
member of the Department of Pathology, Hamamatsu
Medical University, School of Medicine, Hamamatsu,
Japan.
In the article entitled “Complement Factor H Is Critical in
the Maintenance of Retinal Perfusion” (Volume 175, pages
412–421 of the July 2009 issue), the authors inadvertently
omitted a funding source. This work was supported by the
Wellcome Trust (WT074617) to J.B.
In the article entitled, “Involvement of CYR61 and
CTGF in the Fascin-Mediated Proliferation and Invasive-
ness of Esophageal Squamous Cell Carcinomas Cells”
(Volume 176, pages 939–951 of the February 2010 is-
sue), the first sentence of the Abstract contained a large
text deletion. The correct first sentence should read as
“Fascin is overexpressed in esophageal squamous cell
carcinoma (ESCC) and involved in the proliferation and
invasiveness of ESCC cells.” This error occurred in the
print article only; the online (HTML and PDF) versions of
this article appear correctly.
In the article entitled, “Human Peripheral Lymphoid
Tissues Contain Autoimmune Regulator-Expressing Den-
dritic Cells” (Volume 176, pages 1104–1112 of the March
2010 issue), Table 2 states that cytokeratins 8/18/19 were
detected using antibody CAM5.2 manufactured by BD
Biosciences (Mm/lgG2a/CAM5.2/1:50/BD). Although pre-
vious BD product inserts indicated that CAM5.2 recog-
nized keratins number 19, 18, and 8, current BD product
inserts report that CAM5.2 antibody mainly labels cyto-
keratins 8 and 7.
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